Related Experiment Videos
Leucocyte adhesion molecules and alcoholic liver disease
1Liver Laboratories, Queen Elizabeth Hospital, Edgbaston, Birmingham, U.K.
Alcohol and Alcoholism (Oxford, Oxfordshire)
|May 1, 1994
Summary
Inflammation drives alcoholic liver disease. Targeting leucocyte adhesion molecules may offer new therapies for alcoholic hepatitis and cirrhosis by controlling immune cell infiltration and damage.
Area of Science:
- Hepatology
- Immunology
- Gastroenterology
Background:
- Alcoholic liver disease pathogenesis is not fully understood.
- Inflammation is increasingly recognized as a key factor in alcohol-induced liver damage and fibrosis.
- Both alcoholic hepatitis and cirrhosis involve liver inflammation, with distinct cellular infiltrates.
Purpose of the Study:
- To explore the role of leucocyte adhesion molecules in alcoholic liver disease.
- To investigate how these molecules influence leucocyte recruitment and hepatocyte damage.
- To identify potential therapeutic targets for alcoholic liver disease.
Main Methods:
- Review of animal experiments and human studies on alcoholic liver disease.
- Analysis of the role of leucocyte adhesion and their counter-receptors.
- Examination of specific adhesion pathways in leucocyte recruitment and cell-mediated damage.
Main Results:
- Leucocyte adhesion molecules are crucial for immune cell migration and function in the liver.
- Specific adhesion pathways are implicated in leucocyte recruitment to the liver in alcoholic liver disease.
- These pathways also play a role in alcohol-induced cell-mediated hepatocyte damage.
Conclusions:
- Leucocyte adhesion pathways are critical in the inflammatory processes of alcoholic liver disease.
- Targeting leucocyte adhesion molecules presents a potential therapeutic strategy.
- Blocking these molecules could offer effective treatment for specific patient groups with alcoholic liver disease.